A Phase 1b, Open-label Single dose study to Evaluate the Pharmacokinetics, Safety and Tolerability of MK-7655A in Pediatric Subjects from Birth to less than 18 years of Age with Confirmed or Suspected Gramnegative Infections
Clinical Trial Grant
Administered By
Pediatrics, Infectious Diseases
Awarded By
Merck Sharp & Dohme
Start Date
August 16, 2017
End Date
September 30, 2020
Administered By
Pediatrics, Infectious Diseases
Awarded By
Merck Sharp & Dohme
Start Date
August 16, 2017
End Date
September 30, 2020